FARHANA TORI: Open Payments
NPI 1588337604 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 55 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,310
Food & beverage: $2,310
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $454 |
| GENZYME CORPORATION | 13 | $352 |
| AERIN MEDICAL INC. | 11 | $345 |
| Lilly USA, LLC | 3 | $152 |
| Alnylam Pharmaceuticals Inc. | 1 | $138 |
| SANOFI US SERVICES INC. | 1 | $132 |
| Globus Medical, Inc. | 1 | $130 |
| Novo Nordisk Inc | 1 | $125 |
| Alkermes, Inc. | 1 | $125 |
| Optinose US, Inc. | 6 | $123 |
Products named: DUPIXENT, VIVAER STYLUS, Xhance, ONPATTRO, ZEPBOUND, AYVAKIT, Senza, VIVITROL.
Industry payments across TX — which companies pay providers there.
